New Leaf Venture Partners’ Liam Ratcliffe, M.D., Ph.D., Elected to Array BioPharma, Inc.’s Board of Directors

NEW YORK--(BUSINESS WIRE)--New Leaf Venture Partners (NLV Partners) announced today that General Partner Liam Ratcliffe, M.D., Ph.D., has been elected as Independent Director to the Board of Directors of Array BioPharma Inc. Dr. Ratcliffe has extensive background in drug development and translational medicine, including a 12-year tenure at Pfizer.
MORE ON THIS TOPIC